Cancer treatments in development (and immunotherapy-based)..Getting the spotlight and the big dollar$..... https://finance.yahoo.com/news/german-merck-pfizer-cancer-immunotherapy-081207013.html - And, Dr. Berendt appears to be doing all the right things to put MCNA onto the red carpet. Will be very interesting especially as pharma/ biotechs continue to show strength based on S&P500 Health Care Index results. And, recall back in July 2009, just after the bottoming of the worst financial crisis since the Great Depression, the former management signed a deal with Endo paying Bioniche up-front cash payment of $20M USD and the potential for up to an additional $110M USD in additional payments linked to the achievement of future clinical, regulatory, and commercial milestones. The deal followed, the publishing of Bioniche's Phase II Bladder Cancer Trial Results in The Journal of Urology in Feb 2009 and the completing of recruitment in first Phase 3 clinical trial in March 2009. A meek benchmark for Dr. Berendt to blow by many multiples. rg